right, from the lows AFTER the IND approval, right? It dropped like a rock after the IND approval, correct? This stock is not going to move up much unless it gets significant funding or a legit partner to help fund it in trials. Again, it isn't that difficult to understand why the stock is where it is right now.

And why are you taking this so personally? The CEO has a history of destroying companies he has founded. BMSN and ENTB to start. The therapies they are working on might just work but you have to get them into clinical trials and they have failed to do that. Hemaxellerate should be in trials now but the company has yet to start them. That's not good.